Library of tools
Tools description
This tool is designed to construct nano-specific species sensitivity distributions (SSD) used in environmental hazard assessment. The nano-specific Species Sensitivity Weighted Distribution (nSSWD) can be accessed as part in the SUN Decision Support System (SUNDS). The approach is based on three species weighting criteria (i.e. species relevance, trophic level abundance and data quality) as well as weighting factors for data quality and the extent of physico-chemical characterisation of the tested nanomaterial in each study. SSD curves are calculated for hazard concentrations (HCx) for 5%, 50% and 95% of species.
SimpleBox4nano is a regulatory-relevant multimedia environmental fate model that is specifically fit for use with nanomaterials. The tool predicts background concentrations of nanomaterials in air, water, sediment and soil. SimpleBox4Nano does so by simultaneously solving mass balance equations for each environmental compartment box in the model. It is a first-principles model in the sense that it internally derives mass flow rates from physical and chemical substance properties, and characteristics of the environment modeled. It takes user-specified release rates as input, producing exposure concentrations in the environment as output.
The SUNDS web tool covers risk management and sustainability of nano-enabled products along their life cycle. It is based on a tiered approach including a decision support tool and a risk assessment and control part. It is based on REACH guidelines and focuses on assessment models. Besides traditional risk assessment and risk management information, the system also asks for the inclusion of sustainability data supporting safer-by-design nano-enabled products (this includes life cycle assessment, social and economic impact assessments). The tool covers human and environmental exposure, hazard and risk assessment.
The LICARA Tool supports SMEs in their decision-making process. It does this by scanning both the benefits and risks over the nanoproduct's life time. It uses a structured life cycle approach which enables the evaluation of the benefits and risks qualitatively with low and manageable efforts, over the nanoproduct's life time. It further allows a comparison with the risks and benefits of the conventional (non-nano) products. The tool stimulates economic, environmental and social opportunities. This tool is specifically intended for use by SMEs to support them in communicating with regulators, and potential clients and investors.
The precautionary matrix for synthetic nanomaterials is geared toward industry and trade. The precautionary matrix is a method for assessing the nano-specific health and environmental risks of nanoproducts. The precautionary matrix enables the structured assessment of the “nano-specific need for precautions” when handling synthetic nanomaterials. The precautionary matrix is designed to help industry and trade comply with their due diligence and their duty to exercise self-control opposite employees, consumers and the environment.
GUIDEnano is a risk assessment model that allows the assessment and mitigation of human and environmental risks related to nanomaterials and nano-enabled product, considering their whole life cycle. Using the GUIDEnano Tool, different stakeholders can evaluate and efficiently mitigate possible health risks for workers, consumers and the environment.
The ConsExpo nano tool can be used to estimate inhalation exposure to nanomaterials in consumer spray products. To run the model, user input on different exposure determinants such as the product and its use, the nanomaterial and the environmental conditions is required. Exposure is presented in different measures. The outcome of the assessment is an alveolar load in the lungs as one of the most critical determinants of inflammation of the lungs is both the magnitude and duration of the alveolar load of a nanomaterial. To estimate the alveolar load arising from the use of nano-enabled spray products, ConsExpo nano combines models that estimate the external aerosol concentration in indoor air, with models that estimate the deposition in and clearance of inhaled aerosol from the alveolar region.
This module allows you to qualitatively assess occupational health risks from inhalation exposure to manufactured nanomaterials. Risk management measures may be selected or included in the action plan. “Stoffenmanager Nano” is an extension of Stoffenmanager, which is a knowledge-based platform aimed at reducing exposure risks to hazardous substances and biological agents in the workplace.
NanoSafer is a combined control-banding and risk management tool that enables assessment of the risk level and recommended exposure control associated with production and use of manufactured nanomaterials (e.g., nanoparticles, nanoflakes, nanofibers, and nanotubes) in specific work scenarios. In addition to manufactured nanomaterials, the tool can also be used to assess and manage emissions from nanoparticle-forming processes.
RISKOFDERM is a quantitative model for estimating potential dermal exposure, i.e. the total amount of a substance coming into contact with the protective clothing, work clothing and exposed skin. It includes six dermal exposure operation (DEO) units, where each unit is a cluster of exposure scenarios involving general chemical substances. In the context of nanomaterials, its applicability domain is not yet established. In the present study, the performance of the model, while estimating the dermal exposure to nanomaterials, is tested by comparing its output with experimentally measured dermal exposure levels of nanomaterials on hands.
The Safety Observer app template 'NanoObserver' can be used in measuring safe and healthy working conditions and behaviour with nanomaterials. A template for the free smartphone/tablet app ‘Safety Observer’ has been developed for use in proactive safety rounds in industrial and academic workplaces that work with or are exposed to manufactured nanomaterials (MN). The template can be adapted to a local context and language, and be used by students, workers, faculty, managers and OSH professionals. Safe and unsafe working conditions and behaviour regarding MN in a workplace are observed and counted, such as: 1) MN signage, marking and labelling 2) MN handling, storage and transport 3) Ventilation and filters 4) Personal protective equipment 5) Technical aids 6) Order and tidiness 7) Hygiene 8) Waste storage, recycling and disposal 9) First aid equipment. Comments and photos can be included in the observations with the app, and a final report, including a ‘safety index’, is automatically generated and made available in the app and sent to one’s email for immediate use in improving and reinforcing OSH initiatives.
The approach is specifically applicable to similarity assessment as a basis for grouping of (nanoforms of) chemical substances as well as for classification of the substances according to the Classification, Labeling and Packaging regulation. The unique goal of this approach is to assess data quality in such a way that all the steps are automatized, thus reducing reliance on expert judgment. The analysis starts from available (meta)data as provided in the data entry templates developed by the NanoSafety community and used for import into the eNanoMapper database. The methodology is implemented in the templates as a traffic light system—the providers of the data can see in real time the completeness scores calculated by the system for their datasets in green, yellow, or red.
This online tool provides estimates of indoor exposure to airborne particles and is based on the NIST multizone modeling software, CONTAM. It is couple with a size resolved tool, which is an additional physical model that accounts for the properties of nanoparticles that may impact their transport within the built environment including some beyond those that CONTAM is currently capable of modeling, e.g., coagulation.
The BIORIMADS uses advanced models to support the occupational, consumer and environmental risk assessment of nanomaterials and biomaterials along the lifecycle of nano-enabled consumer products and medical applications. The BIORIMADS addresses nano and biomaterials used in medical applications such as medical devices and advanced therapy medicinal products (ATMPs). In situations where the risks are not controlled the BIORIMADS proposes suitable Risk Management Measures (e.g. engineering controls, Personal Protective Equipment) and provides information about the cost of implementing these measures. Risk control can be demonstrated by reducing risk to below threshold levels or by investigating feasible alternatives to the substance. If the risks cannot be adequately controlled and no feasible alternatives can be found, a Socioeconomic Analysis (SEA) can be performed to demonstrate that the benefits of using a certain nano/biomaterial or application significantly outweigh the risks.
The combined dosimetry model (CoDo) can be used to simulate the exposure concentrations in air corresponding to the doses used in in vitro studies in submerged systems. It works by integrating in vitro dosimetry and lung dosimetry, and assuming that the deposited dose per area in vitro corresponds to the deposited dose per area in the lung. The input data include experimental parameters about the in vitro system and lung parameters that define the hypothetical human exposure scenario; the required parameters and the parameters that, if not specified by the user, are calculated by the model.
The nano Benefit Assessment Matrix (nano-BAM) supports the assessment of functional, health and environmental benefits of nanomaterials, nano-enabled manufactured nanomaterials and products from the first innovation stage until the product is on the market. The BAM assists users to summarize the benefits by assessing two aspects: (i) Degree of benefit (DoB) to estimate how achievable the benefits are and (ii) Degree of evidence (DoE) to understand what scientific evidence is available for the benefit identified by users.
The “Socio-Economic Life Cycle-Based Framework for SSbD” is a tool to perform a socio-economic assessment of nanomaterials and nano-enabled products to support decision-making for safe-and sustainable-by-design (SSbD). The main target user group is industries in the early stages of product development. The framework, based on a social life cycle analysis (S-LCA) and multi-criteria decision analysis (MCDA) methodologies, will help users make decisions that would reduce the negative socio-economic impacts of nanomaterials and nano-enabled products.
Dynamic Probabilistic Material Flow analysis (DPMFA) can be used to predict release of nanomaterials to the environment based on an analysis of the mass flows during the full life cycle from nanomaterial production over use to final end-of-life treatment of nanoenabled products. Main input requirements are data about production amounts, uses in products and transfer coefficients between all compartments, e.g. release or behavior during EoL. The model then quantifies flows into environmental compartments such as water, air, soil and the subsurface. These flows can then be used as input for environmental fate models.
NanoDUFLOW is a nanomaterial environmental fate model that links nanomaterial-specific process descriptions to a spatially explicit hydrological model. The link enables the realistic modelling of feedbacks between local flow conditions and nanomaterial fate processes, such as homo- and heteroaggregation, resuspension and sedimentation. Spatially explicit simulations using five size classes of engineered nanomaterials and five size classes of natural solids showed how nanomaterial sediment contamination ‘hot spots’ and nanomaterial speciation can be predicted as a function of place and time.
ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration. NanoApp helps registrants follow the European Chemical Agency (ECHA)’s new registration requirements for nanomaterials under the EU’s REACH legislation. It does this by creating and justifying ‘sets of similar nanoforms’ for a joint human health and environmental hazard, exposure and safety assessment. The tool uses established criteria and rules that systematically evaluate similarity between nanoforms. On that basis, it concludes whether a set of nanoforms can be justified or not. Its decision logic follows the ECHA guidance in a transparent and evidence-based manner – covering primarily the ‘Appendix for nanoforms applicable to the Guidance on Registration and Substance Identification’.
The model is very useful for the exposure assessment of products containing nanomaterials during shredding (end-of-life), a part of the life cycle where there is little data available. With a Bayesian probabilistic nature in its core, it uses subjective judgement when data is unavailable or scarce while being able to adapt and update risk forecasts as new information becomes available. Its novelty lies on a simplistic approach which combines the material and process variables of the system to determine the probability of number, size, mass and composition of released particles. It is applicable to the shredding of a wide range of nano-enabled products and it aims to reduce the nanomaterial release by using the safe(r)-by-design approach.
Tool to assess risks associated with nanotechnology operations. The tool estimates an emission probability and severity band and provides advice on what engineering controls to use. It includes nine domains covering handling of liquids, powders and abrasion of solids. Combines hazard “severity” scores and exposure “probability” scores in a matrix to obtain a level of risk and associated controls out of 4 possible levels of increasing risk and associated controls. Control banding (CB) strategies (a qualitative risk characterization and management strategy) offer simplified solutions for controlling worker exposures to constituents that are found in the workplace in the absence of firm toxicological and exposure data.
This framework allows to quantify the readiness of different tools and methods towards their wider regulatory acceptance and downstream use by different stakeholders. The framework diagnoses barriers which hinder regulatory acceptance and wider usability of a tool/method based on their Transparency, Reliability, Accessibility, Applicability and Completeness (TRAAC framework). Each TRAAC pillar consists of criteria which help in evaluating the overall quality of the tools and methods for their (i) compatibility with regulatory frameworks and, (ii) usefulness and usability for end-users, through a calculated TRAAC score based on the assessment. Fourteen tools and methods were assessed using the TRAAC framework as proof-of-concept. The results provide insights into any gaps, opportunities, and challenges in the context of each of the 5 pillars of the TRAAC framework.
The Screening Multiple Criteria Decision Analysis (SMCDA) was developed to rank different material options (not only nanomaterials) according to their acceptability in terms of broader environmental and socioeconomic aspects. The criteria used in SMCDA relate to properties of the material that are specific to the production, use, and end-of-life phases. Its structure aims to provide initial guidance even without the knowledge and resources required for a full life cycle analysis. The input questionnaire is divided into three levels that unfold with the user's experience. SMCDA applies weighting to consider the varying relevance of criteria and to improve differentiation among comparable alternatives. The probabilistic approach accounts for uncertainty and missing knowledge. An analysis requires only semi-quantitative estimates without the need for exact numbers, and results can be obtained even with incomplete inputs. SMCDA is intended to be used by various societal actors to contribute to processes of reflexive innovation.
This is a stochastic probabilistic long-term risk prediction tool (working at its best for up to 100 years and more) targeting product material (ingredient) interaction between product life phases and a variety of media and environments. This tool is not mass-flow oriented but builds on probabilistic predictions of the target material's (product ingredient's) location and transformation over its lifecycle and beyond. It performs without predefined (theoretical and other) probability distributions but generates them itself. Its computations integrate humans and environments' risk and vulnerability by combining the load contamination of potential pollutants with toxicity and ecotoxicity data. This tool aims to predict and target specific product ingredients, including newly engineered nanomaterials and their lifecycle-long (up to 50 years) location in and migration through environmental (human) and technical systems. The target compartments and organisms potentially vulnerable or at risk are air, freshwaters, marine waters, groundwater, saline groundwater, freshwater sediments, marine water sediments, soils, freshwater flora, marine water flora, freshwater fauna, marine water fauna and child and adult humans. PERST's services may be used in target regions covering all EU member states, Switzerland and the UK. The main PERST-output forms are 3D graphics with probabilistic information for long time periods, boxplots summarising these outputs distributions over time and line charts visualising the evolution of the target outputs. A product risk etiquette is under construction for evaluating the total risks computed for a target product (product ingredient). More from this info can be found on www.etss.ch/perst/.
This tool is based on the bow-tie model and has been adapted for the the specifics of nanotechnology related risk. The bow-tie model offers a paradigm of engagement across an extended temporal plane as it seeks to engage the risk management function within the insurance industry with mitigation and control measure in the ex-ante phase of analysis. The bow-tie model offers a number of advantages. The fact it is visually represented allows for improved heuristics and this is combined with its ability to deliver quite precise risk metrics. Importantly, for a field such as nanotechnology, the model is open to iterative improvement as more data or more precise probabilistic analysis becomes available. the bow-tie model could be used in conjunction with other methodologies and its adoption in no way precludes the use of other approaches such as control banding. The fact that it is a well understood process by insurers and indeed those in the chemical industry leads us to believe that at this stage it is the best candidate tool or perhaps best method available at this juncture.
Tools to support Life Cycle Impact Assessment
ReCiPe is an impact assessment method within LCA and calculates 18 midpoint indicators and 3 endpoint indicators. Human Toxicity (cancer and non cancer) and Ecotoxicity (terrestrial, marine and freshwater) are included among the impact categories evaluated, but the method has not been adapted to model nanomaterials specifically. The characterization factor of human toxicity and ecotoxicity accounts for the environmental persistence (fate), accumulation in the human food chain (exposure), and toxicity (effect) of a chemical.
USEtox is a model providing midpoint and endpoint characterization factors for human toxicological and freshwater ecotoxicological impacts of emissions in life cycle assessment. Characterization factors are calculated in three steps:
-Environmental fate, modelling the distribution and degradation of substances,
-Exposure, where the exposure of humans, animals and plants is modelled,
-Effects, where the inherent damage of the substance is modelled.
The method has not been adapted to model nanomaterials, but approaches have been proposed to combine USEtox damage and exposure assessment with SimpleBox4nno fate assessment (Salieri et al. 2019).
LCA Software, enabling ISO 14044 compliance
SimaPro is a professional LCA software tool that enables modelling and analysing complex life cycles in a systematic and transparent way.
In the data collection stage, the user can input the amount of material, processes and relative data available in the large databases built in the package, which are collected from a large number of sources related to a variety of assessment methods. The database can be modified and extended based on the customer's requirement. Using its customizable parameters and Monte Carlo analytical capabilities, SimaPro can determine the potential environmental impact that a system or service produces with statistical accuracy. The use of parameters provides flexibility to easily change values or assumptions, which facilitates sensitivity analyses (switching between values), scenario analyses (specify a range of values for a parameter), and defining non-linear relationships.
Gabi 6 is a well-recognised software tool for modelling products and systems from a life cycle perspective. Within GaBi software processes are modelled in the GaBi Plan editor, feeding them with data sets from the GaBi and Ecoinvent databases. On GaBi plans, individual elements of a product or the product life cycle are combined into an overall model using unit processes. Advanced parametrization options are available in order to define variables and dependencies in the model, which can be used to model scenarios.GaBi software provides a wide set of databases. On the other hand, GaBi software provides options to customize reports and export them.
The Umberto LCA software tool is a very flexible and powerful software tool for modelling, calculating, visualizing, and evaluating material and energy flows. It is based on the so-called Petri networks, a special type of network from theoretical informatics which, with its strict systematic, not only allows the setup of complex systems but also a combined material and inventory calculation. The tool enables parametrization and scenario modelling, To facilitate this assessment, easy integration of existing primary data (e.g. by linking Microsoft Excel cell values with Umberto model) is possible. The tool can also integrate the two market leaders databases, Ecoinvent and GaBi.
OpenLCA is a free, open source LCA software. The software does not have a built-in database, but free and for purchase databases can be found on the dedicated website nexus.openlca.org. Moreover, the user can import their own data in a wide range of formats, such as EcoSpold 01 and 02, and ILCD, thanks to the built-in implementation of the format converter functionalities. OpenLCA supports the use of parameters, the calculation of uncertainty via Monte Carlo simulations, and sensitivity analysis.
Tools list
Model/tool | Owner of the tool | Nanospecific | Type of tool | Application domain | Applicable roots of release and exposure | Applicable R&I phase | Cooper stage-gate | Applicable population | Applicable products with EU regulations | Applicable material | Difficulty | Tool output | Short description of tool and references |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stoffenmanager Nano | Cosanta BV | 1. Yes | 1. Control banding | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 4. R&D | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 2. Semi-quantitative | nano.stoffenmanager.com/Default.aspx?lang=en |
Stoffenmanager Nano | 2. Market phase | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||||
Stoffenmanager Nano | 3. Medical devices | 3. Liquid dispersion | |||||||||||
Stoffenmanager Nano | 4. Biocides | 4. Solid reinforced composite | |||||||||||
Stoffenmanager Nano | 5. Food contact materials | ||||||||||||
Stoffenmanager Nano | 6. Food labelling | ||||||||||||
Stoffenmanager Nano | 7. Drugs | ||||||||||||
Nanosafer CB | NRCWE | 1. Yes | 1. Control banding | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 1. Idea | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 2. Semi-quantitative | www.nanosafer.org/ |
Nanosafer CB | 5. Numerical estimate | 2. Screening | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||||
Nanosafer CB | 3. Buisness case | 3. Medical devices | |||||||||||
Nanosafer CB | 4. R&D | 4. Biocides | |||||||||||
Nanosafer CB | 5. validation | 5. Food contact materials | |||||||||||
Nanosafer CB | 6. Launch | 6. Food labelling | |||||||||||
Nanosafer CB | 7. Monitoring | 7. Drugs | |||||||||||
GUIDEnano | LEITAT | 1. Yes | 5. Numerical estimate | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 2. Screening | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 3. Quantitative | tool.guidenano.eu/Home/About |
GUIDEnano | 2. Market phase | 3. Buisness case | 2. Worker | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||
GUIDEnano | 4. R&D | 3. Consumer | 3. Medical devices | 3. Liquid dispersion | |||||||||
GUIDEnano | 5. validation | 4. General population | 4. Biocides | 4. Solid reinforced composite | |||||||||
GUIDEnano | 6. Launch | 5. Food contact materials | |||||||||||
GUIDEnano | 7. Monitoring | 6. Food labelling | |||||||||||
GUIDEnano | 7. Drugs | ||||||||||||
RiskofDerm | TNO | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 2. Dermal only | 1. Design phase | 1. Idea | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 3. Quantitative | www.eurofins.com/media/2245/dermal_toolkit_paper_version-en.pdf |
RiskofDerm | 2. Market phase | 2. Screening | 4. Biocides | 2. Powdered non-spherical particulate | |||||||||
RiskofDerm | 3. Regulatory phase | 3. Buisness case | |||||||||||
RiskofDerm | 4. R&D | ||||||||||||
RiskofDerm | 5. validation | ||||||||||||
RiskofDerm | 6. Launch | ||||||||||||
RiskofDerm | 7. Monitoring | 3. Liquid dispersion | |||||||||||
LICARA nanoSCAN | TNO/EMPA | 1. Yes | 2. Risk Screening | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 1. Idea | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 1. Qualitative | publicationslist.org/data/nowack/ref-160/2014_09_29_Licara%20Guidelines_m_links[1].pdf |
LICARA nanoSCAN | 3. Life cycle assessment | 4. Risk-benefit analysis | 2. Screening | 2. Worker | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||
LICARA nanoSCAN | 3. Buisness case | 3. Consumer | 3. Liquid dispersion | ||||||||||
LICARA nanoSCAN | 4. General population | 4. Biocides | 4. Solid reinforced composite | ||||||||||
LICARA nanoSCAN | |||||||||||||
LICARA nanoSCAN | |||||||||||||
LICARA nanoSCAN | |||||||||||||
Swiss precautionary matrix | Swiss Federal Office of Public Health | 1. Yes | 2. Risk Screening | 1. Release/exposure assessment | 4. All routes | 1. Design phase | 3. Buisness case | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 1. 1-1.9 | 1. Qualitative | www.bag.admin.ch/bag/en/home/gesund-leben/umwelt-und-gesundheit/chemikalien/nanotechnologie/sicherer-umgang-mit-nanomaterialien/vorsorgeraster-nanomaterialien-webanwendung.html |
Swiss precautionary matrix | 3. Life cycle assessment | 2. Hazard assessment | 4. R&D | 2. Worker | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||
Swiss precautionary matrix | 5. validation | 3. Consumer | 3. Medical devices | 3. Liquid dispersion | |||||||||
Swiss precautionary matrix | 6. Launch | 4. Biocides | 4. Solid reinforced composite | ||||||||||
Swiss precautionary matrix | 7. Monitoring | 5. Food contact materials | |||||||||||
Swiss precautionary matrix | 6. Food labelling | ||||||||||||
Swiss precautionary matrix | 7. Drugs | ||||||||||||
Control Banding Nanotool | Lawrence Livermore National Laboratory | 1. Yes | 1. Control banding | 3. Risk assessment (hazard and exposure) | 4. All routes | 1. Design phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 1. Qualitative | controlbanding.llnl.gov/ | |
Control Banding Nanotool | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||||||
Control Banding Nanotool | 3. Medical devices | 3. Liquid dispersion | |||||||||||
Control Banding Nanotool | 4. Biocides | 4. Solid reinforced composite | |||||||||||
Control Banding Nanotool | 5. Food contact materials | ||||||||||||
Control Banding Nanotool | 6. Food labelling | ||||||||||||
Control Banding Nanotool | 7. Drugs | ||||||||||||
DeRmal Exposure Assessment Method (DREAM) | TNO | 2. No | 2. Risk Screening | 1. Release/exposure assessment | 2. Dermal only | 1. Design phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 2. Semi-quantitative | academic.oup.com/annweh/article/47/1/71/131394 | |
DeRmal Exposure Assessment Method (DREAM) | 2. Market phase | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||||
DeRmal Exposure Assessment Method (DREAM) | 3. Medical devices | 3. Liquid dispersion | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1741090/ | ||||||||||
DeRmal Exposure Assessment Method (DREAM) | 4. Biocides | ||||||||||||
DeRmal Exposure Assessment Method (DREAM) | 5. Food contact materials | ||||||||||||
DeRmal Exposure Assessment Method (DREAM) | 6. Food labelling | ||||||||||||
DeRmal Exposure Assessment Method (DREAM) | 7. Drugs | ||||||||||||
DeRmal Exposure Assessment Method (DREAM) | |||||||||||||
ECETOC TRA | ECETOC | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 2. Semi-quantitative | www.ecetoc.org/tools/targeted-risk-assessment-tra/ | |
ECETOC TRA | 2. Dermal only | 2. Market phase | 2. Worker | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||
ECETOC TRA | 3. Regulatory phase | 3. Consumer | 3. Medical devices | 3. Liquid dispersion | |||||||||
ECETOC TRA | 4. Biocides | 4. Solid reinforced composite | |||||||||||
ECETOC TRA | 5. Food contact materials | ||||||||||||
ECETOC TRA | 6. Food labelling | ||||||||||||
ECETOC TRA | 7. Drugs | ||||||||||||
Consexpo Nano Tool | RIVM | 1. Yes | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Screening | 3. Consumer | 1. Chemical substances | 3. Liquid dispersion | 1. 1-1.9 | 3. Quantitative | www.rivm.nl/en/consexpo/related-tools/nano-tool/about |
Consexpo Nano Tool | 3. Buisness case | ||||||||||||
Consexpo Nano Tool | 4. R&D | ||||||||||||
Consexpo Nano Tool | 5. validation | ||||||||||||
Consexpo Nano Tool | 6. Launch | ||||||||||||
Consexpo Nano Tool | 7. Monitoring | 4. Biocides | |||||||||||
Advanced REACH Tool (ART) | HSL | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Screening | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.advancedreachtool.com/ |
Advanced REACH Tool (ART) | 2. Market phase | 3. Buisness case | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||||
Advanced REACH Tool (ART) | 3. Regulatory phase | 4. R&D | 3. Medical devices | 3. Liquid dispersion | |||||||||
Advanced REACH Tool (ART) | 5. validation | 4. Biocides | 4. Solid reinforced composite | ||||||||||
Advanced REACH Tool (ART) | 6. Launch | 5. Food contact materials | |||||||||||
Advanced REACH Tool (ART) | 7. Monitoring | 6. Food labelling | |||||||||||
Advanced REACH Tool (ART) | 7. Drugs | ||||||||||||
Advanced REACH Tool (ART) | |||||||||||||
SprayExpo model | BAUA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Screening | 2. Worker | 1. Chemical substances | 3. Liquid dispersion | 6. N/A | 3. Quantitative | www.baua.de/EN/Topics/Chemicals-biological-agents/Hazardous-substances/Assessment-unit-biocides/Sprayexpo |
SprayExpo model | 2. Dermal only | 2. Market phase | 3. Buisness case | 4. Biocides | www.baua.de/DE/Angebote/Publikationen/Berichte/F2137.pdf?__blob=publicationFile&v=2 | ||||||||
SprayExpo model | 4. R&D | ||||||||||||
SprayExpo model | 5. validation | ||||||||||||
SprayExpo model | 6. Launch | ||||||||||||
SprayExpo model | 3. Regulatory phase | 7. Monitoring | |||||||||||
British Aerosol Manufacturers Association indoor air model | British Aerosol Manufacturers Association (BAMA) | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Worker | 1. Chemical substances | 3. Liquid dispersion | 6. N/A | 3. Quantitative | bama.co.uk/library/230 | |
British Aerosol Manufacturers Association indoor air model | 2. Dermal only | 2. Market phase | 3. Consumer | 4. Biocides | |||||||||
British Aerosol Manufacturers Association indoor air model | 3. Regulatory phase | ||||||||||||
NANOSOLUTIONS | FIOH | 1. Yes | 2. Risk Screening | 2. Hazard assessment | N/A | 1. Design phase | 2. Worker | 1. Chemical substances | N/A | 6. N/A | 2. Semi-quantitative | cordis.europa.eu/project/id/309329 | |
NANOSOLUTIONS | 3. Consumer | 2. Cosmetic products | |||||||||||
NANOSOLUTIONS | 4. General population | 3. Medical devices | |||||||||||
NANOSOLUTIONS | 4. Biocides | ||||||||||||
NANOSOLUTIONS | 5. Food contact materials | ||||||||||||
NANOSOLUTIONS | 6. Food labelling | ||||||||||||
NANOSOLUTIONS | 7. Drugs | ||||||||||||
ESIG-EGRET | European Solvents Industry Group (ESIG) | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 3. Consumer | 1. Chemical substances | 3. Liquid dispersion | 6. N/A | 2. Semi-quantitative | www.ncbi.nlm.nih.gov/pmc/articles/PMC3941027/pdf/jes2012128a.pdf | |
ESIG-EGRET | 6. Database | 2. Dermal only | 2. Market phase | 2. Cosmetic products | |||||||||
ESIG-EGRET | 3. Regulatory phase | 3. Medical devices | https://www.esig.org/reach-ges/consumers/ | ||||||||||
ESIG-EGRET | 4. Biocides | ||||||||||||
ESIG-EGRET | 5. Food contact materials | ||||||||||||
ESIG-EGRET | 6. Food labelling | ||||||||||||
ESIG-EGRET | 7. Drugs | ||||||||||||
ESIG-EGRET | |||||||||||||
SimpleBox4Nano screening fate assessment model | RIVM | 1. Yes | 5. Numerical estimate | 1. Release/exposure assessment | 5. Environmental | 3. Regulatory phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 2. 2-2.9 | 3. Quantitative | SimpleBox4nano is a regulatory-relevant multimedia fate model that is specifically fit for use with nanomaterials. The tool predicts background concentrations of nanomaterials in air, water, sediment and soil using nested regional, continental and global scale compartments. | |
SimpleBox4Nano screening fate assessment model | 8. Environmental fate | 4. Biocides | |||||||||||
SimpleBox4Nano screening fate assessment model | |||||||||||||
SimpleBox4Nano screening fate assessment model | |||||||||||||
SimpleBox4Nano screening fate assessment model | 5. Food contact materials | ||||||||||||
SimpleBox4Nano screening fate assessment model | 6. Food labelling | ||||||||||||
SimpleBox4Nano screening fate assessment model | 7. Drugs | ||||||||||||
SimpleBox4Nano screening fate assessment model | |||||||||||||
SUNDS | Universita Ca' Foscari Venezia | 1. Yes | 2. Risk Screening | 3. Risk assessment (hazard and exposure) | 4. All routes | 1. Design phase | 1. Idea | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 2. 2-2.9 | 1. Qualitative | cordis.europa.eu/docs/results/604/604305/final1-sun-final-report-20170525.pdf |
SUNDS | 3. Life cycle assessment | 4. Risk-benefit analysis | 2. Market phase | 2. Screening | 2. Worker | 2. Cosmetic products | 2. Powdered non-spherical particulate | 3. Quantitative | |||||
SUNDS | 5. Numerical estimate | 5. Social impact assessment | 3. Regulatory phase | 3. Buisness case | 3. Consumer | 3. Medical devices | 3. Liquid dispersion | ||||||
SUNDS | 6. Economic impact assessment | 4. R&D | 4. General population | 4. Biocides | 4. Solid reinforced composite | ||||||||
SUNDS | 5. validation | 5. Food contact materials | |||||||||||
SUNDS | 6. Launch | 6. Food labelling | |||||||||||
SUNDS | 7. Monitoring | 7. Drugs | |||||||||||
SUNDS | |||||||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | ARA (Applied research associates) | 3. Partly | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | Computational particle dosimetry model for airborne particles that can be used for estimating human and test animal airway particle dosimetry. The model is applicable to risk assessment, research, and education. The MPPD model calculates the deposition and clearance of monodisperse and polydisperse aerosols in the respiratory tracts of rats and human adults and children (deposition only) for particles ranging in size from ultrafine (0.01 µm) to coarse (20 µm). The models are based on single-path and multiple-path methods for tracking air flow and calculating aerosol deposition in the lung. The single-path method calculates deposition in a typical path per airway generation, while the multiple-path method calculates particle deposition in all airways of the lung and provides lobar-specific and airway-specific information. Within each airway, deposition is calculated using theoretically derived efficiencies for deposition by diffusion, sedimentation, and impaction within the airway or airway bifurcation. Filtration of aerosols by the nose and mouth is determined using empirical efficiency functions. The MPPD model includes calculations of particle clearance in the lung following deposition. | |
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 2. Market phase | 3. Consumer | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 3. Regulatory phase | 4. General population | 3. Medical devices | 3. Liquid dispersion | https://www.ara.com/mppd/ | ||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 4. Biocides | 4. Solid reinforced composite | |||||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 5. Food contact materials | ||||||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 6. Food labelling | ||||||||||||
Multiple-Path Particle Dosimetry Model (MPPD v 3.04) | 7. Drugs | ||||||||||||
Dynamic probabilistic material flow model (DP-MFA) | EMPA | 1. Yes | 5. Numerical estimate | 1. Release/exposure assessment | 5. Environmental | 3. Regulatory phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 4. 4-4.9 | 3. Quantitative | A DPMFA modeling framework combining dynamic material flow modeling with probabilistic modeling. Material transfers that lead to particular environmental stocks are represented as systems of mass-balanced flows. The time-dynamic behavior of the system is calculated by adding up the flows over several consecutive periods, considering changes in the inflow to the system and intermediate delays in local stocks. Incomplete parameter knowledge is represented and propagated using Bayesian modeling. The method is implemented as a simulation framework in Python to support experts from different domains in the development of their application models. | |
Dynamic probabilistic material flow model (DP-MFA) | 2. Cosmetic products | 2. Powdered non-spherical particulate | |||||||||||
Dynamic probabilistic material flow model (DP-MFA) | 3. Medical devices | 3. Liquid dispersion | pypi.python.org/pypi/dpmfa-simulator | ||||||||||
Dynamic probabilistic material flow model (DP-MFA) | 4. Biocides | 4. Solid reinforced composite | |||||||||||
Dynamic probabilistic material flow model (DP-MFA) | 5. Food contact materials | ||||||||||||
Dynamic probabilistic material flow model (DP-MFA) | 6. Food labelling | ||||||||||||
Dynamic probabilistic material flow model (DP-MFA) | 7. Drugs | ||||||||||||
NanoDUFLOW | Wageingen University & Research (WUR) | 1. Yes | 5. Numerical estimate | 8. Environmental fate | 5. Environmental | 3. Regulatory phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 5. = 5 | 3. Quantitative | NanoDUFLOW is a spatially resolved hydrological ENP fate model, that was validated using measurements of inert particulates. | |
NanoDUFLOW | 4. Biocides | ||||||||||||
NanoDUFLOW | |||||||||||||
NanoDUFLOW | |||||||||||||
DF4nanoGrouping | ECETOC | 1. Yes | 4. Framework | 2. Hazard assessment | 1. Inhalation only | 3. Regulatory phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 1. Qualitative | A decision analytical tool to facilitate the grouping of NMs for the purpose of read-across for RA was proposed by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) ”Nano Task Force”. The tool consists of 3 tiers to assign NMs to 4 main groups: i) soluble NMs, ii) biopersistent high aspect ratio NMs, iii) passive NMs, and iv) active NMs. The tool performs sub-grouping within the main groups to determine and refine nanospecific information needs. The DF4nanoGrouping approach covers all relevant aspects of NM life cycles and biological pathways such as intrinsic material and system-dependent properties, biopersistence, uptake and biodistribution, cellular and apical toxic effects. Use, release and route of exposure are applied as 'qualifiers' in order to determine if the NM can be released from a product matrix; if not, the tool could suggest waiving of irrelevant testing. One distinguishing nanospecific feature of DF4nanoGrouping is that it groups NMs by their specific modes of action that result in apical toxic effects. | |
DF4nanoGrouping | 3. Consumer | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||||
DF4nanoGrouping | 4. General population | 3. Liquid dispersion | www.ecetoc.org/topics/nanotechnology/ | ||||||||||
DF4nanoGrouping | 4. Solid reinforced composite | ||||||||||||
ISO/TS 12901-2:2014 Nanotechnologies | ISO | 1. Yes | 7. Guidance document | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 1. Idea | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 3. 3-3.9 | 2. Semi-quantitative | ISO/TS 12901-2:2014 Nanotechnologies - Occupational risk management applied to engineered nanomaterials - Part 2: Use of the control banding approach |
Occupational risk management applied to engineered nanomaterials | 3. Regulatory phase | 2. Screening | 2. Powdered non-spherical particulate | ||||||||||
Part 2: Use of the control banding approach | 3. Buisness case | 3. Liquid dispersion | www.iso.org/standard/53375.html | ||||||||||
4. R&D | 4. Solid reinforced composite | ||||||||||||
Bayesian Networks | NanoNextNL | 1. Yes | 2. Risk Screening | 2. Hazard assessment | 4. All routes | 1. Design phase | 2. Worker | 1. Chemical substances | 6. N/A | 3. Quantitative | A Bayesian Network (BN) for the prediction of the hazard potential and biological effects with the focus on metal- and metal-oxide NMs to support human health risk assessment. The developed BN captures the (inter)relationships between the exposure route, the NMs' physicochemical properties and the ultimate biological effects in a holistic manner and was based on international expert consultation and the scientific literature (e.g., in vitro/in vivo data). The BN was validated with independent data extracted from published studies and the accuracy of the prediction of the nanomaterials hazard potential was 72% and for the biological effect 71%, respectively. It is demonstrated that the BN may be used by different stakeholders at several stages in the risk assessment to predict certain properties of NMs of which little information is available or to prioritize NMs for further screening. | ||
Bayesian Networks | 5. Numerical estimate | 2. Market phase | 3. Consumer | Marvin HJP, Bouzembrak Y, Janssen EM, van der Zande M, Murphy F, Sheehan B, Mullins M, Bouwmeester H, 2017. Application of Bayesian networks for hazard | |||||||||
Bayesian Networks | 3. Regulatory phase | 4. General population | |||||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | Department of Environmental Sciences, Informatics, and Statistics, University Ca’ Foscari, Venice | 1. Yes | 5. Numerical estimate | 2. Hazard assessment | 5. Environmental | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | An approach to the ecological risk assessment of engineered NMs is proposed that can operate in the context of high uncertainty. This approach further develops species sensitivity weighted distribution (SSWD) by including three weighting criteria (species relevance, trophic level abundance, and nanotoxicity data quality) to address nanospecific needs. | |
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 2. Market phase | 2. Cosmetic products | 2. Powdered non-spherical particulate | Semenzin E, Lanzellotto E, Hristozov D, Critto A, Zabeo A, Giubilato E, Marcomini A, 2015. Species sensitivity weighted distribution for ecological risk assessment of engineered nanomaterials: The n-TiO2 case study. Environmental Toxicology and Chemistry 34 (11): 2644–2659, DOI: 10.1002/etc.3103 | |||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 3. Regulatory phase | 3. Medical devices | 3. Liquid dispersion | ||||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 4. Biocides | 4. Solid reinforced composite | |||||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 5. Food contact materials | ||||||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 6. Food labelling | ||||||||||||
Nano Species Sensitivity Weighted Distribution (n-SSWD) | 7. Drugs | ||||||||||||
NanoProteinCorona (Enalos platform) | NanoMILE / NovaMechanics Ltd | 1. Yes | 8. Guidance tool | 2. Hazard assessment | 4. All routes | 3. Regulatory phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | A predictive model for the assessment of the biological response of surface-modified gold NPs in the form of cellular association, including both internalized and surface-attached NPs, based on their physicochemical properties and protein corona fingerprints. A dataset of 105 unique NPs was used for developing the model. Cellular association is relevant to inflammatory responses, biodistribution, and toxicity in vivo. The validated predictive model is can be used as part of a regulatory or NP safe-by-design decision support system. This online tool allows the virtual screening of NPs to identify those that warrant further toxicity testing on the basis of predicted NP cellular association. www.tandfonline.com/doi/full/10.1080/17435390.2018.1504998 | |
NanoProteinCorona (Enalos platform) | 5. numerical estimate | 2. Worker | Afantitis A, Melagraki G, Tsoumanis A, Valsami-Jones E, Lynch I, 2018. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints. Nanotoxicology 12 (10): 1148‒1165, DOI: 10.1080/17435390.2018.1504998 | ||||||||||
NanoProteinCorona (Enalos platform) | 3. Consumer | ||||||||||||
NanoProteinCorona (Enalos platform) | 4. General population | www.enaloscloud.novamechanics.com/nanocommons/NanoProteinCorona/ | |||||||||||
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform) | NanoMILE / NovaMechanics Ltd | 1. Yes | 5. Numerical estimate | 2. Hazard assessment | 4. All routes | 3. Regulatory phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | A predictive classification model for the toxicological assessment of iron oxide nanoparticles with different core, coating and surface modification based on a number of different properties including size, relaxivities, zeta potential and type of coating. The model successfully fulfilled the criteria recommended by the OECD for model validation, i.e. was validated both internally and externally in terms of goodness-of-fit, robustness and predictivity (see Publication). | |
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform) | 3. Risk assessment and/or management (hazard and exposure) | 3. Consumer | 2. Powdered non-spherical particulate | Lynch I, Afantitis A, Leonis G, Melagraki G, Valsami-Jones E, 2017. Strategy for Identification of Nanomaterials’ Critical Properties Linked to Biological Impacts: Interlinking of Experimental and Computational Approaches. In: Roy K. (eds) Advances in QSAR Modeling. Challenges and Advances in Computational Chemistry and Physics, vol 24. Springer, Cham, pp. 385‒424 Melagraki G, Afantitis A, 2015. A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform. Current Topics in Medicinal Chemistry 15(18): 1827‒1836, DOI: 10.2174/1568026615666150506144536 | |||||||||
Risk Assessment Tool for the Virtual Screening of NPs (Enalos platform) | 4. General population | www.enaloscloud.novamechanics.com/EnalosWebApps/QNAR_IronOxide_Toxicity/ | |||||||||||
nano-lazar | eNanoMapper | 1. Yes | 4. Framework | 2. Hazard assessment | 4. All routes | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | nano-lazar is a modular framework for read-across predictions of chemical toxicities. Within the eNanoMapper project, lazar was extended with capabilities to handle nanomaterial data, interfaces to other eNanoMapper services (databases from data.enanomapper.net and ontologies) and a stable and user-friendly graphical interface for nanoparticle read-across predictions. | ||
nano-lazar | 2. Market phase | 2. Worker | 2. Powdered non-spherical particulate | Helma C, Rautenberg M, Gebele D, 2017. Nano-Lazar: Read across Predictions for Nanoparticle Toxicities with Calculated and Measured Properties. Front. Pharmacol. 8: 377, DOI: 10.3389/fphar.2017.00377 | |||||||||
nano-lazar | 3. Regulatory phase | 3. Consumer | 3. Liquid dispersion | https://www.enanomapper.net/modelling | |||||||||
nano-lazar | 4. General population | nano-lazar.in-silico.ch/ | |||||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | Pacific Northwest National Laboratory and for Nano applications: Harvard University (prof. Philip Demokritou) | 3. Partly | 5. Numerical estimate | 2. Hazard assessment | 4. All routes | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | A computational model to assess the biological effective dose of particles in in vitro systems. The model makes it possible to calculate the per area mass, surface area, and number of particles, as well as the fraction of total suspended material deposited as a function of time. This provides a ground-breaking improvement in dosimetry accuracy and enabled meaningful hazard rankings among NMs. The ISDD software (see Link) is available as code (requiring Matlab) and as a Windows executable file. Adaptations for nanoparticles have been also published (see Publications). | |
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 2. Market phase | 2. Worker | 2. Cosmetic products | Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG, 2010. ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7(1): 36, DOI: 10.1186/1743-8977-7-36 | |||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 3. Regulatory phase | 3. Consumer | 3. Medical devices | Cohen JM, Teeguarden JG, Demokritou P, 2014. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol 11: 20, DOI: 10.1186/1743-8977-11-20 | |||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 4. Biocides | DeLoid GM, Cohen JM, Pyrgiotakis G, Pirela SV, Pal A, Liu J, Srebric J, Demokritou P, 2015. Advanced computational modeling for in vitro nanomaterial dosimetry. Part Fibre Toxicol 12: 32, DOI: 10.1186/s12989-015-0109-1 | |||||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 5. Food contact materials | Cohen JM, DeLoid GM, Demokritou P, 2015. A critical review of in vitro dosimetry for engineered nanomaterials. Nanomedicine 10(19): 3015‒3032, DOI: 10.2217/nnm.15.129 | |||||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 6. Food labelling | ||||||||||||
In vitro Sedimentation, Diffusion and Dosimetry model (ISDD) | 7. Drugs | www.pnnl.gov/projects/vitro-dosimetry | |||||||||||
Nano-QRA | 1. Yes | 6. Database/management | 2. Hazard assessment | 4. All routes | 1. Design phase | N/A | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | A quantitative read-across approach for NMs that addresses and overcomes a basic limitation of existing methods with a simple and effective algorithm for filling data gaps in quantitative manner, providing predictions of the missing data. It is based on one-point-slope, two-point formula, or the equation of a plane passing through three points. | ||
Nano-QRA | 7. Guidance document | 7. Material characterization | 2. Powdered non-spherical particulate | ||||||||||
Nano-QRA | 3. Liquid dispersion | Gajewicz A, Jagiello K, Cronin MTD, Leszczynskic J, Puzyn T, 2017. Addressing a bottle neck for regulation of nanomaterials: quantitative read-across (Nano-QRA) algorithm for cases when only limited data is available. Environ Sci: Nano 4, 346‒358, DOI: 10.1039/C6EN00399K | |||||||||||
Consexpo | RIVM | 2. No | 2. Risk Screening | 1. Release/exposure assessment | 4. All routes | 1. Design phase | 2. Screening | 3. Consumer | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.rivm.nl/en/consexpo |
Consexpo | 5. Numerical estimate | 2. Market phase | 3. Buisness case | 2. Cosmetic products | 2. Powdered non-spherical particulate | ||||||||
Consexpo | 3. Regulatory phase | 4. R&D | 4. Biocides | ||||||||||
Consexpo | 5. validation | ||||||||||||
Consexpo | 6. Launch | ||||||||||||
Consexpo | 7. Monitoring | ||||||||||||
Consexpo | 5. Food contact materials | ||||||||||||
MEASE | EBRC | 2. No | 5. Numerical estimate | 1. Release/exposure assesment | 1. Inhalation only | 3. Regulatory phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.ebrc.de/industrial-chemicals-reach/projects-and-references/mease.php | |
MEASE | 2. Powdered non-spherical particulate | ||||||||||||
MEASE | 3. Liquid suspension | ||||||||||||
MEASE | |||||||||||||
ENAE CPSC | NIST | 1. Yes | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 2. Market phase | 2. Screening | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 2. 2-2.9 | 3. Quantitative | pages.nist.gov/CONTAM-apps/webapps/NanoParticleTool/index.htm |
ENAE CPSC | 2. Dermal only | 3. Buisness case | |||||||||||
ENAE CPSC | 4. R&D | ||||||||||||
ENAE CPSC | 5. validation | ||||||||||||
ENAE CPSC | 6. Launch | ||||||||||||
ENAE CPSC | 7. Monitoring | 3. Consumer | 2. Powder non-spherical particulate | ||||||||||
EMKG Expo tool | BAuA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 2. Semi-quantitative | www.baua.de/EN/Service/Publications/Guidance/EMKG-Expo-Tool-2.html | |
EMKG Expo tool | 2. Market phase | 2. Powdered non-spherical particulate | |||||||||||
EMKG Expo tool | 3. Regulatory phase | 3. Liquid suspension | |||||||||||
CEM | EPA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 2. Market phase | 3. Consumer | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.epa.gov/tsca-screening-tools/cem-consumer-exposure-model-download-and-install-instructions | |
CEM | 2. Dermal only | 2. Powdered non-spherical particulate | |||||||||||
CEM | 3. Ingestion only | 3. Liquid suspension | |||||||||||
ChemSTEER | EPA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.epa.gov/tsca-screening-tools/chemsteer-chemical-screening-tool-exposures-and-environmental-releases | |
ChemSTEER | 2. Dermal only | 2. Market phase | 2. Worker | 2. Powdered non-spherical particulate | |||||||||
ChemSTEER | 3. Regulatory phase | 3. Liquid suspension | |||||||||||
E-FAST | EPA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 1. Design phase | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | www.epa.gov/tsca-screening-tools/e-fast-exposure-and-fate-assessment-screening-tool-version-2014 | |
E-FAST | 8. Environmental fate | 2. Dermal only | 2. Market phase | 2. Worker | 2. Powdered non-spherical particulate | ||||||||
E-FAST | 3. Ingestion only | 3. Regulatory phase | 3. Consumer | 3. Liquid suspension | |||||||||
E-FAST | 4. General population | ||||||||||||
WPEM | EPA | 2. No | 5. Numerical estimate | 1. Release/exposure assessment | 1. Inhalation only | 2. Market phase | 2. Worker | 1. Chemical substances | 3. Liquid suspension | 6. N/A | 3. Quantitative | www.epa.gov/tsca-screening-tools/wpem-wall-paint-exposure-model-questions-and-answers | |
WPEM | 3. Consumer | ||||||||||||
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section) | ITENE | 1. Yes | 5. Numerical estimate | 3. Risk assessment (hazard and exposure) | 4. All routes | 1. Design phase | 1. Idea | 1. Environment | 1. Chemical substances | 1. Powdered spherical particulate | 3. Quantitative | sunds.gd/biorima/biorimaSelection | |
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section) | 2. Market phase | 2. Screening | 2. Worker | 3.Medical devices | 3. Liquid disperion | 1. 1-1.9 | |||||||
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section) | 3. Regulatory phase | 3. Buisness case | |||||||||||
BIORIMA (Risk assessemnt and risk control module - Occupational exposure section) | 4. R&D | ||||||||||||
Stoffenmanager | Cosanta BV | 2. No | 5. Numerical estimate | 3. Risk assessment (hazard and exposure) | 1. Inhalation only | 1. Design phase | 1. Idea | 2. Worker | 1. Chemical substances | 1. Powdered spherical particulate | 6. N/A | 3. Quantitative | |
Stoffenmanager | 2. Market phase | 2. Screening | 3. Liquid dispersion | ||||||||||
Stoffenmanager | 3. Regulatory phase | 3. Buisness case | |||||||||||
Stoffenmanager | 4. R&D | ||||||||||||
Stoffenmanager | 5. validation | ||||||||||||
Stoffenmanager | 6. Launch |